We are live on ! Find out more
CTNM

Contineum Therapeutics
CTNM

90 hedge funds and large institutions have $399M invested in Contineum Therapeutics in 2026 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 29 increasing their positions, 21 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 11

38% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 21

18% more capital invested

Capital invested by funds: $338M → $399M (+$60.7M)

13% more funds holding

Funds holding: 80 → 90 (+10)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

34.64% less ownership

Funds ownership: 128.15% → 93.52% (-35%)

Holders
90
Holders Change
+10
Holders Change %
+12.5%
% of All Funds
1.11%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
22
Increased
29
Reduced
21
Closed
11
Calls
$148K
Puts
–
Net Calls
+$148K
Net Calls Change
+$191K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$9.45M
2
IC
Ikarian Capital
Texas
+$7.04M
3
Citadel Advisors
Citadel Advisors
Florida
+$4.7M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$3.83M
5
LP
Longaeva Partners
Illinois
+$3.52M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$11.9M
2
CC
Commodore Capital
New York
-$9.33M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$9.04M
4
PA
Perceptive Advisors
New York
-$2.8M
5
Ameriprise
Ameriprise
Minnesota
-$2.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
BCM
51
Bridgeway Capital Management
Texas
$644K – – –
TI
52
Trexquant Investment
Connecticut
$624K -$151K -11,285 -19%
Bank of America
53
Bank of America
North Carolina
$620K +$512K +38,180 +412%
Barclays
54
Barclays
United Kingdom
$574K -$209K -15,549 -26%
Hudson Bay Capital Management
55
Hudson Bay Capital Management
Connecticut
$559K +$226K +16,880 +65%
BHCM
56
Brevan Howard Capital Management
Jersey
$551K +$305K +22,752 +117%
BNP Paribas Financial Markets
57
BNP Paribas Financial Markets
France
$521K -$327K -24,349 -38%
Two Sigma Investments
58
Two Sigma Investments
New York
$495K – – –
XT
59
XTX Topco
Cayman Islands
$468K +$481K +35,846 New
American Century Companies
60
American Century Companies
Missouri
$466K +$217K +16,159 +83%
SFCM
61
Seven Fleet Capital Management
California
$353K +$363K +27,054 New
IFG
62
Independent Financial Group
California
$353K – – –
JG
63
Jain Global
New York
$300K +$308K +22,984 New
HF
64
HRT Financial
New York
$289K +$297K +22,170 New
Canada Pension Plan Investment Board
65
Canada Pension Plan Investment Board
Ontario, Canada
$269K +$276K +20,600 New
RC
66
RBF Capital
California
$261K – – –
QL
67
Quarry LP
New York
$209K +$215K +16,000 New
EGM
68
Engineers Gate Manager
New York
$195K +$201K +14,956 New
OAC
69
OMERS Administration Corp
Ontario, Canada
$185K -$278K -20,700 -59%
CUAMC
70
China Universal Asset Management Company
China
$176K +$131K +9,739 +259%
CGIM
71
Cannon Global Investment Management
Florida
$170K +$174K +13,000 New
QC
72
Quadrature Capital
United Kingdom
$167K -$142K -10,578 -45%
ECM
73
ExodusPoint Capital Management
New York
$162K -$518K -38,646 -76%
T. Rowe Price Associates
74
T. Rowe Price Associates
Maryland
$148K – – –
DC
75
Diametric Capital
Massachusetts
$140K +$144K +10,729 New
1 2
3
4 5

CTNM Hedge Fund Activity: Q1 2026 in Review

90 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Contineum Therapeutics (CTNM) for Q1 2026, worth a combined $399M — up 18% from $338M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new CTNM positions and 11 closed out — a net gain of 11 holders — while 29 added to existing stakes and 21 trimmed.

The largest buyer was Millennium Management, adding an estimated $9.45M. The largest seller was RA Capital Management, cutting an estimated $11.9M.

  • 90 institutional investors held Contineum Therapeutics (CTNM) as of Q1 2026, up from 80 in Q4 2025.
  • Funds reported $399M of Contineum Therapeutics stock for Q1 2026, up 18% quarter-over-quarter.
  • 22 funds opened new Contineum Therapeutics positions in Q1 2026 and 11 closed out, a net change of +11 holders.
  • The largest Contineum Therapeutics buyer in Q1 2026 was Millennium Management, an estimated $9.45M added.
  • The largest Contineum Therapeutics seller in Q1 2026 was RA Capital Management, an estimated $11.9M sold.

Based on aggregated 13F filings for Q1 2026.